CareDx Inc CDNA
News
CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer
CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of CareDx, Inc. (NASDAQ: CDNA)
CareDx to Report Second Quarter 2024 Financial Results